Annual report pursuant to Section 13 and 15(d)

Commitments and Contingencies - Narrative (Details)

v3.24.1
Commitments and Contingencies - Narrative (Details)
$ in Thousands
 12 Months Ended
Jul. 19, 2022
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Mar. 31, 2023
site
Nov. 15, 2022
May 01, 2021
period
Other Commitments [Line Items]            
Number of successive periods | period           4
Agreement term, successive periods (in years)         1 year 1 year
Agreement term (in days)           90 days
General and administration   $ 34,502 $ 34,385      
Number of sites | site       8    
Linebacker License Agreements            
Other Commitments [Line Items]            
Upfront license fee $ 50          
License agreement term (in days) 10 days          
License or royalty net revenue percentage 3.00%          
Minimum royalty $ 250          
General and administration   600 $ 500      
Equivir License Agreement            
Other Commitments [Line Items]            
General and administration   400        
BE-Smart License Agreement            
Other Commitments [Line Items]            
General and administration   $ 300        
Phase Three | Linebacker License Agreements            
Other Commitments [Line Items]            
Additional payment of fee 900          
New Drug Application | Linebacker License Agreements            
Other Commitments [Line Items]            
Additional payment of fee $ 1,000